Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein

for fondaparinux sodium. [2018] 1.11.4 Consider intermittent pneumatic compression for people with fragility fractures of the pelvis, hip or proximal femur at the time of admission if pharmacological prophylaxis is contraindicated. Continue until the person no longer has significantly reduced mobility relative to their normal or anticipated mobility. [2018] Elective hip replacement In March 2018: • the use of LMWH and rivaroxaban in young people under 18 in recommendation 1.11.5 was off label • the use of aspirin in recommendation 1.11.5 was off label • the use of apixaban and dabigatran etexilate in young people under 18 in recommendation 1.11.6 was off label. See NICE's information on prescribing medicines. 1.11.5 Offer VTE prophylaxis to people undergoing elective hip replacement surgery whose risk of VTE outweighs their risk of bleeding. Choose any one of: • LMWH for 10 days followed by aspirin (75 mg or 150 mg) for a further 28 days. • LMWH for 28 days combined with anti-embolism stockings (until discharge). • Rivaroxaban, which is recommended as an option in NICE technology appraisal guidance for preventing venous thromboembolism in adults after elective hip replacement surgery. For full details, see the guidance on rivaroxaban (TA170, 2009). [2018] 1.11.6 Consider one
